A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD (NCT06208306)
A Double-blinded Extension Study to Evaluate the Long-term Safety and Tolerability of Itepekimab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Participated in Either EFC16750 or EFC16819 Clinical Studies
🩺 Plain-English Summary (8th-Grade Level)
This is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment response, and provide additional PK and immunogenicity assessments. The primary purpose of this study is to evaluate safety and tolerability of both itepekimab SC Q2W or itepekimab SC Q4W in participants with COPD having completed the treatment period of the clinical studies EFC16750 or EFC16819. A secondary purpose of this study is to provide efficacy outcomes beyond the treatment period of the parent trials EFC16750 and EFC16819. Study details include: * The study duration will be up to 72 weeks * The treatment duration will be up to 52 weeks * A follow-up period of 20 weeks will be conducted * The number of on-site visits will be 7 and the number of phone contacts will be 5
Who can join: Review the eligibility criteria below.
Location: Chandler Clinical Research Trials- Site Number : 8401034 — Chandler, Arizona
Age range: 40 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (223 Sites)
Showing the first 25 of 223 sites.
- Chandler Clinical Research Trials- Site Number : 8401034 — Chandler, Arizona
- Noble Clinical Research Site Number : 8401182 — Tucson, Arizona
- Tucson Clinical Research Institute- Site Number : 8401431 — Tucson, Arizona
- IMAX Clinical Trials- Site Number : 8401419 — La Palma, California
- Antelope Valley Clinical Trials Site Number : 8401003 — Lancaster, California
- Downtown L.A. Research Center- Site Number : 8401027 — Los Angeles, California
- Allianz Research Institute CO Site Number : 8402061 — Aurora, Colorado
- Alpine Clinical Research Center - Boulder - 47th Street- Site Number : 8401180 — Boulder, Colorado
- Helix Biomedics- Site Number : 8402049 — Boynton Beach, Florida
- Beautiful Minds Clinical Research Center Site Number : 8401201 — Cutler Bay, Florida
- Omega Research Consultants - Debary - North Charles Richard Beall Boulevard- Site Number : 8402031 — DeBary, Florida
- Science Connections, LLC Site Number : 8402045 — Doral, Florida
- Direct Helpers Research Center- Site Number : 8402065 — Hialeah, Florida
- Premier Medical Associates Site Number : 8401388 — Lady Lake, Florida
- Advanced Pulmonary Research Institute Site Number : 8402018 — Loxahatchee Groves, Florida
- Finlay Medical Research- Site Number : 8402007 — Miami, Florida
- Elite Clinical Research - Miami- Site Number : 8402009 — Miami, Florida
- DL Research Solutions- Site Number : 8401033 — Miami, Florida
- My Community Research Center Site Number : 8402060 — Miami, Florida
- Phoenix Medical Research - Miami - 24th Street- Site Number : 8402019 — Miami, Florida
- Research Institute of South Florida- Site Number : 8401006 — Miami, Florida
- Reed Medical Research Site Number : 8401032 — Miami, Florida
- High Quality Research Site Number : 8401406 — Miami, Florida
- Deluxe Health Center Site Number : 8401188 — Miami Lakes, Florida
- Renstar Medical Research - Ocala - Northeast 1st Avenue- Site Number : 8402015 — Ocala, Florida
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Obstructive Pulmonary Disease
- Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects — Hershey, Pennsylvania
- Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD — Miami, Florida
- A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD — Bakersfield, California
- A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Birmingham, Alabama
- Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease — Birmingham, Alabama
Explore by condition: All Chronic Obstructive Pulmonary Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.